NCT07485699

Brief Summary

Soy allergies are widespread and are becoming increasingly significant today as people around the world consume more and more soy and soy-containing foods. Soy is used in many products and undergoes various processing steps such as heating, extraction, enzymatic degradation, and preservation. However, it is not yet fully understood how these processing steps affect soy's ability to trigger allergic reactions. The goal of this project is to process soy in various controlled ways and investigate how these methods affect its allergenic potential. First, the effects will be tested in the laboratory (in vitro). Subsequently, the results will be examined in humans using a skin prick test (SPT) to determine how the processed soy affects allergic reactions

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
38mo left

Started May 2026

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress5%
May 2026Aug 2029

First Submitted

Initial submission to the registry

March 16, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 20, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

May 31, 2026

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2029

Last Updated

March 20, 2026

Status Verified

March 1, 2026

Enrollment Period

2.3 years

First QC Date

March 16, 2026

Last Update Submit

March 16, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Frequency of sensitization (in vitro/in vivo) to processed soy proteins

    Frequency of sensitization (in vitro/in vivo) to processed soy proteins compared to unprocessed soy proteins in patients with known soy allergy

    one-time (in-vitro diagnostic/skin prick test)

Secondary Outcomes (3)

  • Sensitization patterns in primary and secondary soy allergy

    one time (skin prick test, in vitro diagnostic)

  • Degree of sensitization of soy allergic patients;

    one time (skin prick test)

  • Correlation with clinical characteristics

    one time (skin prick test)

Study Arms (3)

primary soy allergy

OTHER

in-vitro-tests and skin prick test (SPT) in patients with primary soy allergy

Procedure: Skin prick test (SPT)

secondary soy allergy

OTHER

in-vitro-tests and skin prick test (SPT) in patients with secondary soy allergy

Procedure: Skin prick test (SPT)

controls

OTHER

in-vitro-tests and skin prick test (SPT) in participants without soy allergy

Procedure: Skin prick test (SPT)

Interventions

skin prick test according SOPs

controlsprimary soy allergysecondary soy allergy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-75
  • Signed informed consent
  • primary soy allergy or secondary soy allergy or control (no soy allergy)

You may not qualify if:

  • Use of antihistamines within 3 days, systemic corticosteroids within 2 weeks, topical corticosteroids (test area) 1 week prior
  • Use of immunosuppressive or biologic agents
  • Active malignancy / ongoing treatment for a malignancy
  • Active or recurrent bacterial, fungal, or viral infection
  • Pregnancy
  • Drug or alcohol abuse, or any condition likely to impair compliance (e.g., language barrier, cognitive disorder, psychological illness)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Patch Tests

Intervention Hierarchy (Ancestors)

Skin TestsImmunologic TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative TechniquesImmunologic Techniques

Study Officials

  • Marie-Charlotte Brüggen, MD PhD

    University of Zurich

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Studienteam Allergologie

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: in vitro test and skin prick test in three patient groups (primary soy allergy, secondary soy allergy, controls)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 16, 2026

First Posted

March 20, 2026

Study Start

May 31, 2026

Primary Completion (Estimated)

August 31, 2028

Study Completion (Estimated)

August 31, 2029

Last Updated

March 20, 2026

Record last verified: 2026-03